The latest research showed that fgl2 deficiency decreases macrophage infiltration and shifts macrophage phenotypes 27; thus, we speculate that fgl2 may influence the disease progression of NASH by regulating the function of macrophages. The gene discussed is FGL2; the disease is metabolic dysfunction-associated steatohepatitis.